Lenire

Neuromod Devices operates the Lenire Tinnitus channel to share clinical research on their FDA-authorized bimodal neuromodulation device for tinnitus treatment. The company publishes findings from European clinical trials and real-world implementations through this platform. Their content draws from studies published in the American Journal of Audiology and other peer-reviewed publications. The Lenire device has undergone extensive testing with over 1,000 clinical trial participants and documentation of outcomes from more than 10,000 European users. Treatment protocols combine auditory and somatosensory neuromodulation delivered through specialized hardware. The platform presents detailed efficacy data, treatment protocols, and longitudinal outcome tracking from these implementations. Healthcare providers, audiologists, and clinical researchers can access technical specifications, trial methodologies, and patient response data through this channel. Content includes procedural documentation, comparative analyses of pre and post-treatment metrics, and detailed study methodologies. The resource serves as a centralized repository for Lenire's published clinical evidence and treatment protocols.